Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J (1997) 4.28

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med (1998) 3.72

Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest (2003) 3.02

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med (1999) 2.76

Cytotoxic T cells and viral hepatitis. J Clin Invest (1997) 2.46

Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A (2003) 2.34

Apoptosis: a mechanism of acute and chronic liver injury. Gut (2005) 2.33

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med (2007) 2.32

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol (2000) 2.23

Hepatocyte death: a clear and present danger. Physiol Rev (2010) 2.18

High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut (1998) 1.88

Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86

Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure. Gut (2006) 1.82

Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut (1999) 1.75

Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology (2014) 1.73

Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest (2003) 1.73

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol (1999) 1.72

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci U S A (1997) 1.68

Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer Cell (2006) 1.54

Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol (2000) 1.39

CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med (1999) 1.39

Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci U S A (1997) 1.37

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med (1996) 1.34

Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology (2009) 1.31

Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol (1997) 1.29

Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol (1999) 1.29

Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest (1998) 1.28

Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol (1999) 1.25

Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway. Am J Pathol (2001) 1.20

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol (1997) 1.18

Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect Immun (1998) 1.18

Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist. Proc Natl Acad Sci U S A (2013) 1.16

The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest (1998) 1.09

Death receptors as targets for anti-cancer therapy. J Cell Mol Med (2008) 1.07

Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice. Toxicol Appl Pharmacol (2012) 1.06

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas. Br J Cancer (1999) 1.06

Death receptor-ligand systems in cancer, cell death, and inflammation. Cold Spring Harb Perspect Biol (2013) 1.03

Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules. Immunology (1997) 1.02

Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol (2004) 1.01

Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci (2014) 1.01

Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut (2004) 1.01

NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol (2013) 1.00

Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology (2009) 0.99

Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection. J Virol (2000) 0.98

Aging accelerates but life-long dietary restriction suppresses apoptosis-related Fas expression on hepatocytes. Am J Pathol (1997) 0.98

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol (1998) 0.98

Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol Biol Cell (2003) 0.97

The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage. J Clin Immunol (1997) 0.96

Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame. Am J Pathol (2007) 0.96

Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease. PLoS One (2011) 0.95

Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction. Virology (2005) 0.95

A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One (2012) 0.94

Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect Immun (1997) 0.94

Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis. Clin Exp Immunol (1999) 0.94

Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis. Proc Natl Acad Sci U S A (2000) 0.93

Foxp3 expression in liver correlates with the degree but not the cause of inflammation. Mediators Inflamm (2011) 0.92

In vivo monitoring of liver damage using caspase-3 probe. Theranostics (2012) 0.92

Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. J Clin Invest (2000) 0.92

Effects of minocycline on Fas-mediated fulminant hepatitis in mice. Br J Pharmacol (2005) 0.91

Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage. Hepatology (2011) 0.90

Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver. J Virol (2002) 0.90

Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int (2012) 0.90

Identification of amino acid residues important for ligand binding to Fas. J Exp Med (1997) 0.89

Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung. J Virol (1999) 0.88

Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J Virol (2004) 0.88

Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem (2009) 0.88

Adhesion of lymphocytes to hepatic endothelium. Mol Pathol (1999) 0.87

Acute ethanol pretreatment increases FAS-mediated liver injury in mice: role of oxidative stress and CYP2E1-dependent and -independent pathways. Free Radic Biol Med (2006) 0.86

Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res (2009) 0.86

The role of innate immunity in HBV infection. Semin Immunopathol (2012) 0.85

Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci (2007) 0.85

Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway. Clin Exp Immunol (1999) 0.85

Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models. Mol Cancer (2009) 0.85

Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol (2014) 0.85

The efficiency of CAPE on retardation of hepatic fibrosis in biliary obstructed rats. J Mol Histol (2011) 0.83

Chronic ethanol feeding potentiates Fas Jo2-induced hepatotoxicity: role of CYP2E1 and TNF-alpha and activation of JNK and P38 MAP kinase. Free Radic Biol Med (2009) 0.82

APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases. Indian J Hum Genet (2009) 0.82

Caspase inhibitors for the treatment of hepatitis C. Clin Liver Dis (2009) 0.82

Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infect Immun (2005) 0.81

Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis. J Clin Immunol (2000) 0.81

Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice. Am J Pathol (2000) 0.81

The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma. Hepat Mon (2012) 0.81

Differential regulation of inflammation and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice. J Hepatol (2014) 0.81

Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology (2016) 0.80

MORT1/FADD is involved in liver regeneration. World J Gastroenterol (2005) 0.80

Significance of increased expression of decoy receptor 3 in chronic liver disease. Dig Liver Dis (2009) 0.80

Participation of the Fas and Fas ligand systems in apoptosis during atrophy of the rat submandibular glands. Int J Exp Pathol (2007) 0.80

c-Myc partially mediates IFNgamma-induced apoptosis in the primary hepatocyte. Int J Exp Pathol (2007) 0.80

Apoptosis in chronic viral hepatitis parallels histological activity: an immunohistochemical investigation using anti-activated caspase-3 and M30 cytodeath antibody. Int J Exp Pathol (2005) 0.79

Crucial Fas-Fas ligand interaction in spontaneous acceptance of hepatic allografts in mice. Immunology (2002) 0.79

Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL. Mol Ther Nucleic Acids (2016) 0.79

The effect of dexamethasone on the generation of plasma DNA from dead and dying cells. Am J Pathol (2004) 0.79

Fas (CD95, Apo-1) ligand gene transfer. J Clin Immunol (2001) 0.78

Immune-mediated Liver Injury in Hepatitis B Virus Infection. Immune Netw (2015) 0.78

Acute ethanol gavage attenuates hemorrhage/resuscitation-induced hepatic oxidative stress in rats. Oxid Med Cell Longev (2012) 0.78

Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice. PLoS One (2013) 0.78

Oxysterol-binding protein-related protein 8 (ORP8) increases sensitivity of hepatocellular carcinoma cells to Fas-mediated apoptosis. J Biol Chem (2015) 0.77

No eczema without keratinocyte death. J Clin Invest (2000) 0.77

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell (1994) 9.25

Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature (1995) 8.23

Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med (1989) 7.07

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (1994) 5.58

Acute liver failure: redefining the syndromes. Lancet (1993) 4.99

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med (1993) 4.53

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell (1994) 4.26

The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol (1992) 4.17

An evolutionary perspective on apoptosis. Cell (1994) 3.77

Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48

HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol (1993) 3.42

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13

Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med (1994) 3.11

Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity (1994) 2.59

Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41

Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci U S A (1994) 2.09

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1994) 2.04

Programmed cell death, apoptosis and killer genes. Immunol Today (1993) 1.98

Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol (1992) 1.94

Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci (1992) 1.90

Regulation of apoptosis in the immune system. Curr Opin Immunol (1994) 1.89

Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc Natl Acad Sci U S A (1986) 1.85

Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur J Immunol (1994) 1.58

gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol (1994) 1.50

In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology (1994) 1.42

Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res (1994) 1.41

T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol (1994) 1.40

Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun (1994) 1.39

A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur J Immunol (1994) 1.32

Cell-mediated cytotoxicity: contact and secreted factors. Curr Opin Immunol (1993) 1.27

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology (1990) 1.25

Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology (1989) 1.10

Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J Hepatol (1988) 0.96

Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur J Cancer (1993) 0.93

Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci Rep (1992) 0.91

Histological patterns of prolonged hepatitis C infection. Gastroenterol Jpn (1993) 0.90

Hepatitis B virus biology and pathogenesis. Mol Genet Med (1992) 0.87

Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene (1982) 13.62

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07

Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83

Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature (1995) 8.23

Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60

A new sensitive method for qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene (1984) 7.36

Nucleotide sequence of bacteriophage fd DNA. Nucleic Acids Res (1978) 7.25

Nucleotide sequence of an RNA polymerase binding site from the DNA of bacteriophage fd. Proc Natl Acad Sci U S A (1975) 7.14

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 6.23

Structural analysis of Tn5. Cold Spring Harb Symp Quant Biol (1981) 6.16

High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81

A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74

Nucleotide sequence of the origin of replication of the Escherichia coli K-12 chromosome. Proc Natl Acad Sci U S A (1979) 5.31

The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol (1990) 5.19

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09

Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95

Interaction of RNA polymerase with promoters from bacteriophage fd. Eur J Biochem (1977) 4.94

Penicillinase from Bacillus licheniformis: nucleotide sequence of the gene and implications for the biosynthesis of a secretory protein in a Gram-positive bacterium. Nucleic Acids Res (1981) 4.94

The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ (2003) 4.72

Comparative sequence analysis of duck and human hepatitis B virus genomes. J Med Virol (1985) 4.68

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68

Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc Natl Acad Sci U S A (1984) 4.62

Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J (1997) 4.56

T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med (1982) 4.51

Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J Exp Med (1985) 4.47

Replication strategy of human hepatitis B virus. J Virol (1987) 4.42

Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31

Long-term survival in patients with hereditary hemochromatosis. Gastroenterology (1996) 4.00

Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol (1986) 3.89

Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81

Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J (1992) 3.78

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73

FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72

Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet (2001) 3.62

Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (1995) 3.59

Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57

The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J (1988) 3.52

Structure of the orgin of DNA replication of bacteriophage fd. Proc Natl Acad Sci U S A (1978) 3.52

Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44

The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol (1987) 3.39

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A (1994) 3.34

The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem (1999) 3.32

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32

Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins. Cell (1989) 3.31

Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13

Function of DNA polymerase 3 in DNA replication. Nat New Biol (1971) 3.10

A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology (1990) 3.03

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity (2000) 2.99

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem (2001) 2.94

Expression and replication of the hepatitis B virus genome under foreign promoter control. Nucleic Acids Res (1987) 2.94

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91

Initiation of deoxyribonucleic acid synthesis. VII. A unique location of the gap in the M13 replicative duplex synthesized in vitro. J Biol Chem (1974) 2.85

Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80

Affinity chromatography of DNA-binding enzymes on single-stranded DNA-agarose columns. Eur J Biochem (1972) 2.76

Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol (1990) 2.72

Structure of the DNA of bacteriophage fd. II. Isolation and characterization of a DNA fraction with double strand-like properties. J Mol Biol (1969) 2.71

Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol (2004) 2.70

Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med (1996) 2.65

Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64

Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64

Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Res (1981) 2.61

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem (1999) 2.52

Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins. J Virol (1987) 2.50

Single RNA polymerase binding site isolated. Nat New Biol (1972) 2.47

The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol (1989) 2.47

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med (1997) 2.46

Mapping and characterization of promoters in bacteriophages fd, f1 and m13. J Mol Biol (1975) 2.46

Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol (1993) 2.45

Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42

Hepatitis B virus replication. Trends Microbiol (1993) 2.41

B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth. Proc Natl Acad Sci U S A (1985) 2.41

FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol (2001) 2.39

Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32

Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res (1997) 2.32

Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun (2001) 2.30

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem (1997) 2.29

Structure of the Abelson murine leukemia virus genome. Cell (1979) 2.27

Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol (1989) 2.27

Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell (1990) 2.26

Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26

TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25